Site search

Supporting help text


To stop breast cancer for good by improving early diagnosis, developing new treatments and preventing all types of breast cancer

Breakthrough Breast Cancer


We’re determined to stop women dying from breast cancer, and making sure every woman receives the treatment she needs is the first step.

That’s why it’s vital that when new drugs are developed, they’re made available to everyone who needs them. This is particularly true for secondary breast cancer drugs, which can give patients more freedom from side effects and, crucially, more time.

Unfortunately, the highly innovative drugs that are currently being developed are too expensive to be approved for routine use on the NHS – the last three breast cancer drugs to be assessed by NICE have been rejected because they are not considered to be cost-effective. These drugs can’t cure secondary breast cancer, but they are proven to give women months of good quality extra time with their families. Secondary breast cancer is a terminal disease and, for now, these drugs offer the best hope for women and their families.

The system isn’t working for patients and we need to fix it. And breast cancer patients and their families are paying the price for the failures of the pharmaceutical industry and of the Government to find a long-term solution.

It’s impossible to put a price on life’s precious moments. But it’s not impossible to put a fair price on drugs which could stop more of these moments being missed.